Clinical Trial Update: Decitabine in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating decitabine for myelodysplastic syndromes (also listed for leukemia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED